John-Paul Gallivan
Corporate Officer/Principal at NUCANA PLC
Network origin in John-Paul Gallivan first degree
Entity | Entity type | Industry | |
---|---|---|---|
14
| Public Company | Biotechnology | 14 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to John-Paul Gallivan via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
WILSON THERAPEUTICS AB | Pharmaceuticals: Major | Chairman Director/Board Member | |
Bioenvision, Inc.
Bioenvision, Inc. Medical/Nursing ServicesHealth Services Bioenvision, Inc. engages in the acquisition, development, distribution, and marketing of compounds and technologies for the treatment of cancer. It also develops anti-infective technologies, which includes the OLIGON(R) technology. The company was founded by Christopher B. Wood on August 16, 1996 and is headquartered in New York, NY. | Medical/Nursing Services | Chief Operating Officer | |
The Wayne State University School of Medicine | College/University | Undergraduate Degree | |
Yale College | College/University | Undergraduate Degree | |
AMGEN INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Glycomine, Inc.
Glycomine, Inc. BiotechnologyHealth Technology Glycomine, Inc. engages in the development of therapeutics for diseases which have no treatment options. Its therapeutic approach is to combine replacement therapies such as substrates, enzymes, or proteins with intracellular delivery vehicles consisting of bio-nanomaterials or ligands that target the molecules to the cell interior of clinically relevant organs. It focuses on research of mannose-1-phosphate and Ngly1 enzyme replacement therapy, and observational study of GLY-000. The company was founded in 2014 by Agnes Rafalko and is headquartered in San Carlos, CA. | Biotechnology | Director/Board Member | |
Launch Therapeutics, Inc.
Launch Therapeutics, Inc. Financial ConglomeratesFinance Launch Therapeutics, Inc. provides investment and therapies development services. The CEO of the American company is Anshul Thakral. | Financial Conglomerates | Director/Board Member | |
Anjarium Biosciences AG
Anjarium Biosciences AG BiotechnologyHealth Technology Anjarium Biosciences AG is a Swiss company that focuses on creating a new class of non-viral gene therapies to tackle genetic diseases throughout a patient's lifetime. The company is based in Schlieren, Switzerland. The company's versatile platform leverages breakthrough science and expertise at the interface of genetic medicine, synthetic biology, and nanoparticle engineering to generate a pipeline of advanced gene therapies with unique competitive advantages over current viral-vector based gene therapies. Anjarium's investors include leading international and strategic investors such as Abingworth, Gimv, Omega Funds, Pfizer Ventures, and Surveyor Capital. The company was founded by Joël de Beer, and Stephen Yoo has been the CEO of the company since 2022. | Biotechnology | Director/Board Member | |
Wugen, Inc.
Wugen, Inc. Packaged SoftwareTechnology Services Wugen, Inc. develops CAR-T therapy platform for cancer therapies. The company was founded by Matthew Cooper and John F. DiPersio and is headquartered in St. Louis, MO. | Packaged Software | Director/Board Member | |
Gynesonics, Inc.
Gynesonics, Inc. Medical SpecialtiesHealth Technology Gynesonics, Inc. provides medical devices for women's health. It offers VizAblate System for the transcervical treatment of symptomatic uterine fibroids under intrauterine ultrasound guidance. The company was founded by Jessica grossman in 2005 and is headquartered in Redwood City, CA. | Medical Specialties | Director/Board Member | |
RENEO PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member | |
Stryve Online Ltd.
Stryve Online Ltd. Miscellaneous Commercial ServicesCommercial Services Stryve Online Ltd. is a British company that offers an applicant tracking system designed to improve the hiring process. The company is based in London, UK. The platform is equipped with various features that aim to make the process more efficient. It was founded in 2019 by Edward Chamberlain. | Miscellaneous Commercial Services | Director/Board Member | |
SPRUCE BIOSCIENCES, INC. | Biotechnology | Director/Board Member | |
Exicure Operating Co.
Exicure Operating Co. Pharmaceuticals: MajorHealth Technology Exicure Operating Co. operates as a biopharmaceutical company commercializing spherical nucleic acid constructs as gene regulation and modulation agents for diseases including applications in oncology, dermatology, neurology, and for immune disorders. The SNA constructs allow the use of oligonucleotide-based therapies to treat diseases in a range of tissue types. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in 2011 and is headquartered in Skokie, IL. | Pharmaceuticals: Major | Director/Board Member | |
EXICURE, INC. | Biotechnology | Director/Board Member | |
The Brigham & Women's Hospital, Inc.
The Brigham & Women's Hospital, Inc. Hospital/Nursing ManagementHealth Services The Brigham & Women's Hospital, Inc. provides health care services. The firm offers treatment for cancer, cardio vascular, neurosciences, orthopedic, arthritis, women's health and clinical services. The company was founded in 1980 and is headquartered in Boston, MA. | Hospital/Nursing Management | Corporate Officer/Principal | |
Abingworth LLP
Abingworth LLP Investment ManagersFinance Abingworth LLP (Abingworth) is a venture capital firm founded in the year 1973 Peter Dickson and Anthony Montagu. The firm headquartered in London and additional offices in San Francisco and Boston. Abingworth LLP became part of The Carlyle Group Inc. (NASDAQ: CG) on 3rd August 2022. | Investment Managers | Chief Investment Officer | |
Bain Capital LP
Bain Capital LP Financial ConglomeratesFinance Bain Capital LP engages in provision of investment consulting services. It specializes in private equity, credit, public equity, venture, real estate, double impact, life sciences, and partnership strategies. The company was founded in 1984 and is headquartered in Boston, MA. | Financial Conglomerates | Corporate Officer/Principal | |
VALNEVA | Biotechnology | Director/Board Member | |
University of Cambridge | College/University | Doctorate Degree | |
Dassiet Oy
Dassiet Oy Medical SpecialtiesHealth Technology Onbone Oy develops medical casting and splinting materials for use in the fields of orthopaedics, traumatology and occupational therapy. The company was founded by Petro Antero Kirmo Lahtinen, Antti Pärssinen, Jari Juhani Salo, Matti Eino Olavi Vaheri, and Karri Airola on November 18, 2008 and is headquartered in Oulu, Finland. | Medical Specialties | Director/Board Member | |
ZipLine Medical, Inc.
ZipLine Medical, Inc. Medical SpecialtiesHealth Technology ZipLine Medical, Inc. engages in the development of non-invasive surgical skin closure devices. It offers Zip Surgical,m PreLoc Wound Care, and Zipstitch Consumer platforms. The company was founded by Amir Belson in 2009 and is headquartered in Campbell, CA. | Medical Specialties | Director/Board Member | |
University of Oxford | College/University | Doctorate Degree | |
MVM Partners LLP
MVM Partners LLP Investment ManagersFinance MVM Partners LLP (MVM Partners) is a venture capital firm founded in 1997. The firm is headquartered in London, the United Kingdom. | Investment Managers | Private Equity Investor | |
The General Hospital Corp.
The General Hospital Corp. Hospital/Nursing ManagementHealth Services The General Hospital Corp. provides healthcare services. It offers diagnostic and therapeutic are in every specialty and subspecialty of medicine and surgery. The firm's care center provides cancer, digestive disorders, heart disease, transplantation and vascular medicine services. The company was founded in 1811 and is headquartered in Boston, MA. | Hospital/Nursing Management | Corporate Officer/Principal | |
SPECTRAL AI, INC. | Medical Specialties | Director/Board Member | |
Levitronix Technologies, Inc. | Director/Board Member | ||
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
Yale School of Medicine | College/University | Doctorate Degree | |
STX Group BV
STX Group BV Miscellaneous Commercial ServicesCommercial Services STX Group BV is a leading environmental commodity trader and climate solutions provider that has been at the forefront of the transition towards a low-carbon economy for over 15 years. The private company is based in Amsterdam, Netherlands, and has subsidiaries in the Netherlands. The Dutch company leverages its expertise in accurately pricing pollution and emissions to cultivate trust in market-based solutions to the decarbonization of the economy. STX Group offers trading and corporate climate solutions that ensure money flows to hundreds and thousands of projects that make the world a greener place, while providing corporations with the certified proof-points of their contributions to environmental acquiring vertis and its subsidiary strive. STX Group was founded in 2005 by Tim van der Noordt, who has been the CEO since then. | Miscellaneous Commercial Services | Director/Board Member | |
NOXXON Pharma, Inc. | Director of Finance/CFO | ||
The University of Edinburgh | College/University | Doctorate Degree | |
University of Münster | College/University | Doctorate Degree | |
Freie Universität Berlin | College/University | Corporate Officer/Principal | |
PRA International LLC
PRA International LLC Pharmaceuticals: OtherHealth Technology Part of ICON plc, PRA International LLC is a clinical research organization. The company is based in Raleigh, NC. | Pharmaceuticals: Other | Corporate Officer/Principal | |
Kymab Ltd.
Kymab Ltd. Pharmaceuticals: MajorHealth Technology Kymab Ltd. discovers and develops human monoclonal antibody drugs. It is using mouse embryonic stem cell technology to develop its Kymouse platform that focuses on encompassing the diversity of the B lymphocyte component of the human immune system, and has the potential for expansion of diversity beyond the normal human immune response. Kymab was founded by Allan Bradley in 2009 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Divlal SAS | Chief Executive Officer | ||
University of Paris Jussieu | College/University | Doctorate Degree | |
Sanofi-Aventis Japan | Chief Tech/Sci/R&D Officer | ||
NOXXON Pharma NV Niederlassung Deutschland
NOXXON Pharma NV Niederlassung Deutschland BiotechnologyHealth Technology NOXXON Pharma NV Niederlassung Deutschland operates as a German biotechnology company. The private company is based in Berlin, Germany. | Biotechnology | Director of Finance/CFO | |
Enterin, Inc.
Enterin, Inc. BiotechnologyHealth Technology Enterin, Inc. develops novel compounds that dysfunctional gut-brain axis in patients with neurodegenerative disease. The company was founded by Denise Barbut, Michael A. Zasloff, and William A. Kinney and is headquartered in Philadelphia, PA. | Biotechnology | Director/Board Member | |
Transcelerate Biopharma, Inc.
Transcelerate Biopharma, Inc. BiotechnologyHealth Technology Transcelerate Biopharma, Inc. is a non-profit consortium that collaborates with pharmaceutical and biotechnology companies to improve the delivery of new medicines. The non-profit company is based in King of Prussia, PA. The organization's mission is to identify, prioritize, design, and facilitate implementation of solutions to drive the efficient, effective, and high-quality delivery of new medicines. Transcelerate has 20 member companies and 30+ initiatives focused on improving the patient and site experience, enhancing sponsor efficiencies and drug safety, and harmonizing processes and sharing information. The company was founded by Garry Arthur Neil, and Janice Chang has been the CEO of the company since 2014. | Biotechnology | Chairman | |
Summer Street Research Partners
Summer Street Research Partners Investment Banks/BrokersFinance Founded in 2002, Summer Street Research Partners is an investment banking and securities firm headquartered in Boston, Massachusetts. The firm is a subsidiary of Northland Securities, Inc. and their ultimate parent is Northland Capital Holdings, Inc. They were formerly known as Custom Equity Research, Inc. Summer Street Research firm focuses on the healthcare sector. | Investment Banks/Brokers | Corporate Officer/Principal | |
Dartmouth College | College/University | Undergraduate Degree | |
Columbia Business School | College/University | Masters Business Admin | |
Leerink Partners LLC
Leerink Partners LLC Investment Banks/BrokersFinance Leerink Partners LLC is a full-service brokerage and investment banking firm headquartered in Boston, Massachusetts. The firm was founded by Jeffrey Leerink in 1995 and formerly known as SVB Securities LLC. They rebranded as Leerink Partners in 2023. The firm is a subsidiary of SVB Securities LLC. Leerink Partners provides institutional sales, equity research, institutional trading, and corporate finance and asset management services to the healthcare and technology industries. They offer superior execution capabilities in common stock, convertibles and derivatives with a singular focus on healthcare and a knowledge-led approach. | Investment Banks/Brokers | Corporate Officer/Principal | |
Cowen & Co. LLC
Cowen & Co. LLC Investment Banks/BrokersFinance Cowen & Co. LLC is a SEC-registered broker/dealer headquartered in New York City. The firm was founded in 2004 and is a subsidiary of Cowen Holdings, Inc., ultimately owned by The Toronto-Dominion Bank (TSE: TD) in Canada. Cowen & Co. offers industry-focused investment banking for growth-oriented companies, domain knowledge-driven research and a sales and trading platform for institutional investors. Their institutional sales and trading business serves both equity and fixed-income clients. Sales and trading execution platform is structured around the following key verticals: (1) healthcare (2) technology, telecommunications and media (TMT) (3) REITs and financials (4) aerospace and defense (5) consumer and (6) alternative energy. | Investment Banks/Brokers | Corporate Officer/Principal |
Statistics
International
United States | 33 |
United Kingdom | 8 |
France | 4 |
Germany | 4 |
Sweden | 2 |
Sectoral
Health Technology | 21 |
Consumer Services | 12 |
Finance | 9 |
Health Services | 4 |
Technology Services | 3 |
Operational
Director/Board Member | 49 |
Corporate Officer/Principal | 25 |
Independent Dir/Board Member | 16 |
Chief Tech/Sci/R&D Officer | 13 |
Undergraduate Degree | 10 |
Most connected contacts
Insiders | |
---|---|
Bali Muralidhar | 20 |
Martin Mellish | 16 |
Andrew Kay | 14 |
Elliott Levy | 14 |
Jeffrey Bloss | 13 |
Hugh Griffith | 12 |
Donald Munoz | 11 |
Adam George | 9 |
Theresa Margaret Bruce | 6 |
Cyrille Leperlier | 5 |
Elisabeth Oelmann | 5 |
Stuart Grant | 3 |
Michelle Myers | 3 |
Martin Alexander Quinn | 1 |
- Stock Market
- Insiders
- John-Paul Gallivan
- Company connections